BMCM
LH icon

Bryn Mawr Capital Management’s Labcorp LH Stock Holding History

Bryn Mawr Capital Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634K Sell
2,264
-8
-0.4% -$2.1K 0.03% 260
2026
Q1 		$606K Buy
2,272
+580
+34% +$157K 0.03% 259
2025
Q4 		$425K Sell
1,692
-380
-18% -$101K 0.02% 297
2025
Q3 		$595K Buy
2,072
+5
+0.2% +$1.34K 0.03% 250
2025
Q2 		$543K Buy
2,067
+12
+0.6% +$2.92K 0.03% 259
2025
Q1 		$478K Sell
2,055
-15
-0.7% -$3.64K 0.03% 260
2024
Q4 		$475K Buy
2,070
+1,081
+109% +$248K 0.03% 285
2024
Q3 		$221K Buy
+989
New +$217K 0.01% 380
2024
Q2 		– Sell
-966
Closed -$211K – 402
2024
Q1 		$211K Hold
966
– – 0.01% 382
2023
Q4 		$220K Buy
966
+323
+50% +$67.9K 0.01% 375
2023
Q3 		$129K Buy
+643
New +$136K 0.01% 383

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bryn Mawr Capital Management's LH Position: Q2 2026 in Review

Bryn Mawr Capital Management reduced its Labcorp (LH) stake by 0.35% in Q2 2026, selling an estimated $2.1K and leaving 2,264 shares worth $634K. The position accounts for 0.03% of the portfolio, ranked #260.

Bryn Mawr Capital Management first reported a position in LH in Q3 2023 and has held it in 11 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Bryn Mawr Capital Management held 2,264 shares of Labcorp worth $634K as of Q2 2026.
  • Bryn Mawr Capital Management sold 8 Labcorp shares in Q2 2026, an estimated $2.1K.
  • Labcorp made up 0.03% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #260 holding.
  • Bryn Mawr Capital Management first reported a position in Labcorp in Q3 2023 and has held it in 11 quarters since.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.